These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3325296)

  • 21. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.
    Longoni R; Spina L; Di Chiara G
    Eur J Pharmacol; 1987 Feb; 134(2):163-73. PubMed ID: 2883010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393.
    Cao GH; Perry BD; Woolverton WL
    Pharmacol Biochem Behav; 1992 Feb; 41(2):321-7. PubMed ID: 1349436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress-induced insomnia: opioid-dopamine interactions.
    Fratta W; Collu M; Martellotta MC; Pichiri M; Muntoni F; Gessa GL
    Eur J Pharmacol; 1987 Oct; 142(3):437-40. PubMed ID: 2892686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
    Carboni E; Longoni R; Deidda S; Di Chiara G
    Eur J Pharmacol; 1986 Jun; 125(1):17-22. PubMed ID: 3525197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI; Fletcher GH; Starr MS
    Pharmacol Biochem Behav; 1987 Jan; 26(1):45-7. PubMed ID: 3494255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The D1 dopamine agonist SKF 38393 functions as a discriminative stimulus in rats.
    Kamien JB; Woolverton WL
    Psychopharmacology (Berl); 1985; 87(3):368-70. PubMed ID: 2934759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
    Rouillard C; Bédard P; Falardeau P; Di Paolo T
    Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
    Merchant KM; Gibb JW; Hanson GR
    Eur J Pharmacol; 1989 Feb; 160(3):409-12. PubMed ID: 2565819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
    J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.